Haplotypes of the NR4A2/NURR1 gene and cardiovascular disease: The Rotterdam study

Human Mutation

Volumn 30, Issue 3, 2009, Pages 417-423

  Kardys, Isabella ^a   Van Tiel, Claudia M ^b   De Vries, Carlie J M ^b   Pannekoek, Hans ^b   Uitterlinden, André G ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   De Maat, Moniek P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Coronary disease; Epidemiology; Genetics; NR4A2 NURR1

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR DISEASE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

AGED; AORTA; BLOOD PRESSURE; CALCINOSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY VESSELS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; TRANSCRIPTION FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 61649110462     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20902     Document Type: Article

References (42)

1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte Jr M, Detrano R. 1990. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832.
2. Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B, Pannekoek H, de Vries CJ. 2002. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 106:1530-1535.
3. Arkenbout EK, Dekker RJ, de Vries CJ, Horrevoets AJ, Pannekoek H. 2003a. Focusing on transcription factor families in atherogenesis: the function of LKLF and TR3. Thromb Haemost 89:522-529.
4. Arkenbout EK, van Bragt M, Eldering E, van Bree C, Grimbergen JM, Quax PH, Pannekoek H, de Vries CJ. 2003b. TR3 orphan receptor is expressed in vascular endothelial cells and mediates cell cycle arrest. Arterioscler Thromb Vasc Biol 23:1535-1540.
5. Bonta PI, van Tiel CM, Vos M, Pols TW, van Thienen JV, Ferreira V, Arkenbout EK, Seppen J, Spek CA, van der Poll T, Pannekoek H, de Vries CJ. 2006. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 26:2288-2294.
6. Bonta PI, Pols TW, de Vries CJ. 2007. NR4A nuclear receptors in atherosclerosis and vein-graft disease. Trends Cardiovasc Med 17:105-111.
7. Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jönsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlmann T, Anvret M, Olson L. 2000. NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet 96:808-813.
8. Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L. 2003. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. Am J Med Genet B Neuropsychiatr Genet 120B:51-57.
9. Chen YH, Tsai MT, Shaw CK, Chen CH. 2001. Mutation analysis of the human NR4A2 gene, an essential gene for midbrain dopaminergic neurogenesis, in schizophrenic patients. Am J Med Genet 105:753-757.
10. de Vries CJ, van Achterberg TA, Horrevoets AJ, ten Cate JW, Pannekoek H. 2000. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J Biol Chem 275:23939-23947.
11. Epstein MP, Satten GA. 2003. Inference on haplotype effects in case-control studies using unphased genotype data. Am J Hum Genet 73:1316-1329.
12. Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. 2005. A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol Endocrinol 19:2437-2450.
13. Fumoto T, Yamaguchi T, Hirose F, Osumi T. 2007. Orphan nuclear receptor Nur77 accelerates the initial phase of adipocyte differentiation in 3T3-L1 cells by promoting mitotic clonal expansion. J Biochem (Tokyo) 141:181-192.
14. Healy DG, Abou-Sleiman PM, Ahmadi KR, Gandhi S, Muqit MM, Bhatia KP, Quinn NP, Lees AJ, Holton JL, Revesz T, Wood NW. 2006. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach. Mov Disord 21:1960-1963.
15. Hering R, Petrovic S, Mietz EM, Holzmann C, Berg D, Bauer P, Woitalla D, Müller T, Berger K, Krüger R, Riess O. 2004. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology 62:1231-1232.
16. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC. 2007. Rotterdam study: objectives and design update. Eur J Epidemiol 22:819-829.
17. Ibanez P, Lohmann E, Pollak P, Durif F, Tranchant C, Agid Y, Durr A, Brice A. 2004. Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease. Neurology 62:2133-2134.
18. International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437:1299-1320.
19. Ishiguro H, Okubo Y, Ohtsuki T, Yamakawa-Kobayashi K, Arinami T. 2002. Mutation analysis of the retinoid X receptor beta, nuclear-related receptor 1, and peroxisome proliferator-activated receptor alpha genes in schizophrenia and alcohol dependence: possible haplotype association of nuclear-related receptor 1 gene to alcohol dependence. Am J Med Genet 114:15-23.
20. Iwayama-Shigeno Y, Yamada K, Toyota T, Shimizu H, Hattori E, Yoshitsugu K, Fujisawa T, Yoshida Y, Kobayashi T, Toru M, Kurumaji A, Detera-Wadleigh S, Yoshikawa T. 2003. Distribution of haplotypes derived from three common variants of the NR4A2 gene in Japanese patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 118B:20-24.
21. Kardys I, Kors JA, van der Meer IM, Hofman A, van der Kuip DA, Witteman JC. 2003. Spatial QRS-T angle predicts cardiac death in a general population. Eur Heart J 24:1357-1364.
22. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ. 2003. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55:56-65.
23. Lammi J, Huppunen J, Aarnisalo P. 2004. Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol Endocrinol 18:1546-1557.
24. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK. 2003. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33:85-89.
25. Lee MK, Choi H, Gil M, Nikodem VM. 2006. Regulation of osteoblast differentiation by Nurr1 in MC3T3-E1 cell line and mouse calvarial osteoblasts. J Cell Biochem 99:986-994.
26. Liu D, Jia H, Holmes DI, Stannard A, Zachary I. 2003. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 23:2002-2007.
27. Martinez-Gonzalez J, Rius J, Castello A, Cases-Langhoff C, Badimon L. 2003. Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ Res 92:96-103.
28. Maruyama K, Tsukada T, Ohkura N, Bandoh S, Hosono T, Yamaguchi K. 1998. The NGFI-B subfamily of the nuclear receptor superfamily [Review]. Int J Oncol 12:1237-1243.
29. Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ, Muscat GE. 2005. Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 280:12573-12584.
30. Pei L, Castrillo A, Chen M, Hoffmann A, Tontonoz P. 2005. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 280:29256-29262.
31. Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. 2006. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 12:1048-1055.
32. Ruano D, Macedo A, Dourado A, Soares MJ, Valente J, Coelho I, Santos V, Azevedo MH, Goodman A, Hutz MH, Gama C, Lobato MI, Belmonte-de-Abreu P, Palha JA. 2004. NR4A2 and schizophrenia: lack of association in a Portuguese/Brazilian study. Am J Med Genet B Neuropsychiatr Genet 128B:41-45.
33. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434.
34. Sladek R, Giguere V. 2000. Orphan nuclear receptors: an emerging family of metabolic regulators. Adv Pharmacol 47:23-87.
35. Valdar W, Solberg LC, Gauguier D, Burnett S, Klenerman P, Cookson WO, Taylor MS, Rawlins JN, Mott R, Flint J. 2006a. Genome-wide genetic association of complex traits in heterogeneous stock mice. Nat Genet 38:879-887.
36. Valdar W, Solberg LC, Gauguier D, Cookson WO, Rawlins JN, Mott R, Flint J. 2006b. Genetic and environmental effects on complex traits in mice. Genetics 174:959-984.
37. van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. 2004. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 109:1089-1094.
38. Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, Witteman JC. 2005. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation 112:572-577.
39. Wellenbrock C, Hedrich K, Schafer N, Kasten M, Jacobs H, Schwinger E, Hagenah J, Pramstaller PP, Vieregge P, Klein C. 2003. NR4A2 mutations are rare among European patients with familial Parkinson's disease. Ann Neurol 54:415.
40. WHO. 1992. International Statistical Classification of Diseases and Related Health Problems, 10th revision. Geneva, Switzerland: WHO.
41. Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, Ashizawa T, Lai D, Le WD. 2002. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology 58:881-884.
42. Zheng K, Heydari B, Simon DK. 2003. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch Neurol 60:722-725.